Ticker: CAPR

Company: Nile Therapeutics, Inc.

Person: DUNBAR GEORGE W JR, director

Transaction date: Dec. 19, 2025

Reporting date: Dec. 23, 2025

Average share price: 1.39

Bought 3000.0 shares for 4170.0